Os Therapies INC DEF 14A proxy statements

OS Therapies Incorporated announces its 2026 Annual Meeting of Stockholders, to be held virtually on September 9, 2026, with key proposals including director elections and incentive plan amendments.

OS Therapies Incorporated adjourned its 2025 annual meeting to October 21, 2025, to solicit additional proxies, while also releasing an investor presentation detailing its clinical pipeline and strategic milestones.

OS Therapies Incorporated has filed definitive additional proxy materials with the SEC.

OS Therapies Incorporated will hold its 2025 Annual Meeting to vote on key proposals including director elections, a significant share issuance for an asset acquisition, and an increase in authorized capital stock.

OS Therapies Inc. adjourned its Special Meeting of Stockholders on March 31, 2025, due to the absence of a quorum and will reconvene on April 9, 2025.

OS Therapies Incorporated is seeking stockholder approval for the potential issuance of common stock exceeding 20% of outstanding shares related to the conversion of preferred stock and exercise of warrants from a recent private placement.